3,5-diiodothyronine has been researched along with Liver Steatosis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canesi, L; Compalati, AD; Damonte, G; Gallo, G; Goglia, F; Grasselli, E; Salis, A; Vergani, L; Voci, A | 1 |
| Perry, RJ; Popov, V; Rahimi, Y; Samuel, VT; Snikeris, J; Vatner, DF | 1 |
| Antonelli, A; Barletta, A; Cavaliere, G; De Lange, P; Goglia, F; Lanni, A; Lionetti, L; Lombardi, A; Mollica, MP; Moreno, M | 1 |
| Cioffi, F; Goglia, F; Lanni, A | 1 |
| Canesi, L; Cioffi, F; De Matteis, R; Fugassa, E; Gallo, G; Goglia, F; Grasselli, E; Vergani, L; Voci, A | 1 |
| Canesi, L; De Matteis, R; Demori, I; Gallo, G; Goglia, F; Grasselli, E; Lanni, A; Vergani, L; Voci, A | 1 |
| Antonelli, A; Baccari, GC; de Lange, P; Fallahi, P; Farina, P; Goglia, F; Lanni, A; Lombardi, A; Moreno, M; Ragni, M; Silvestri, E | 1 |
1 review(s) available for 3,5-diiodothyronine and Liver Steatosis
| Article | Year |
|---|---|
Thyroid hormones, mitochondrial bioenergetics and lipid handling.
Topics: Acetates; Adiposity; Anilides; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Diiodothyronines; Dyslipidemias; Energy Metabolism; Fatty Liver; Humans; Lipid Metabolism; Mice; Mitochondria; Obesity; Phenols; Rats; Thyroid Hormones | 2010 |
6 other study(ies) available for 3,5-diiodothyronine and Liver Steatosis
| Article | Year |
|---|---|
3,5-diiodo-L-thyronine modifies the lipid droplet composition in a model of hepatosteatosis.
Topics: Animals; Cell Line, Tumor; Diiodothyronines; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fatty Liver; Intracellular Signaling Peptides and Proteins; Lipase; Lipid Metabolism; Mitochondria, Liver; Models, Biological; Muscle Proteins; Oleic Acid; Oxidation-Reduction; Palmitic Acid; Perilipin-5; Rats | 2014 |
3,5 Diiodo-L-Thyronine (T2) Does Not Prevent Hepatic Steatosis or Insulin Resistance in Fat-Fed Sprague Dawley Rats.
Topics: Animals; Body Composition; Body Weight; Diet, High-Fat; Diiodothyronines; Fatty Liver; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Rats; Rats, Sprague-Dawley; Triglycerides | 2015 |
3,5-diiodo-l-thyronine, by modulating mitochondrial functions, reverses hepatic fat accumulation in rats fed a high-fat diet.
Topics: Alanine Transaminase; Animals; Dietary Fats; Diiodothyronines; Fatty Liver; Lipid Metabolism; Lipids; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Oxidative Stress; Oxygen Consumption; Rats; Rats, Wistar; Thyrotropin; Weight Gain | 2009 |
Direct effects of iodothyronines on excess fat storage in rat hepatocytes.
Topics: Acyl-CoA Oxidase; Animals; Catalase; Cells, Cultured; Diiodothyronines; Fatty Liver; Gene Expression; Hepatocytes; Lipid Metabolism; Non-alcoholic Fatty Liver Disease; Oleic Acid; Palmitates; PPAR alpha; PPAR delta; PPAR gamma; Rats; RNA, Messenger; Superoxide Dismutase; Triiodothyronine | 2011 |
3,5-Diiodo-L-thyronine modulates the expression of genes of lipid metabolism in a rat model of fatty liver.
Topics: Acyl-CoA Oxidase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apolipoproteins B; Diiodothyronines; Fatty Liver; Gene Expression Regulation; Intracellular Signaling Peptides and Proteins; Lipase; Lipid Metabolism; Lipoproteins, VLDL; Liver; Male; Membrane Proteins; Muscle Proteins; Perilipin-2; Perilipin-3; Perilipin-5; Peroxisome Proliferator-Activated Receptors; Protein Isoforms; Random Allocation; Rats; Rats, Wistar; RNA, Messenger; Stearoyl-CoA Desaturase; Vesicular Transport Proteins | 2012 |
3,5-diiodo-L-thyronine powerfully reduces adiposity in rats by increasing the burning of fats.
Topics: Adipose Tissue; Adiposity; AMP-Activated Protein Kinases; Animals; Carnitine O-Palmitoyltransferase; Cholesterol; Dietary Fats; Diiodothyronines; Energy Metabolism; Fatty Acids; Fatty Liver; Liver; Male; Mitochondria, Liver; Multienzyme Complexes; Oxidation-Reduction; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Triglycerides; Weight Gain | 2005 |